LogicBio Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2019 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2019 to Q3 2022.
  • LogicBio Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2022 was -53 %, a 5.22% decline year-over-year.
  • LogicBio Therapeutics, Inc. annual Return On Assets for 2021 was -56.6 %, a 5.16% increase from 2020.
  • LogicBio Therapeutics, Inc. annual Return On Assets for 2020 was -59.7 %, a 0.53% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -53 -2.63 -5.22% Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.9 -1.76 -3.38% Apr 1, 2022 Jun 30, 2022
Q1 2022 -55.9 -0.96 -1.75% Jan 1, 2022 Mar 31, 2022
Q4 2021 -56.6 +3.08 +5.16% Oct 1, 2021 Dec 31, 2021
Q3 2021 -50.4 +26.5 +34.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.1 +21.1 +28.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -54.9 +15.1 +21.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -59.7 +0.32 +0.53% Oct 1, 2020 Dec 31, 2020
Q3 2020 -76.9 -28.4 -58.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -73.2 -25 -51.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -70 Jan 1, 2020 Mar 31, 2020
Q4 2019 -60 Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.5 Jul 1, 2019 Sep 30, 2019
Q2 2019 -48.2 Apr 1, 2019 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.